The mixed lineage leukemia (MLL) gene is disrupted by chromosomal translocations in acute leukemia, producing a fusion oncogene with altered properties relative to the wild-type gene. Murine loss-of-function studies have shown an essential role for Mll in developing the haematopoietic system, yet studies using different conditional knockout models have yielded conflicting results regarding the requirement for Mll during adult steady-state haematopoiesis. In this study, we used a loxP-flanked Mll allele (Mll F ) and a developmentally regulated, haematopoietic-specific VavCre transgene to reassess the consequences of Mll loss in the haematopoietic lineage, without the need for inducers of Cre recombinase. We show that VavCre;Mll mutants exhibit phenotypically normal fetal haematopoiesis, but rarely survive past 3 weeks of age. Surviving animals are anemic, thrombocytopenic and exhibit a significant reduction in bone marrow haematopoietic stem/progenitor populations, consistent with our previous findings using the inducible Mx1Cre transgene. Furthermore, the analysis of VavCre mutants revealed additional defects in B-lymphopoiesis that could not be assessed using Mx1Cremediated Mll deletion. Collectively, these data support the conclusion that Mll has an essential role in sustaining postnatal haematopoiesis.
Introduction
The treatment of childhood leukemia has improved dramatically in the last five decades. However, patients with certain cytogenetic abnormalities do not effectively respond to the conventional chemotherapy, particularly those defined by translocations in the mixed lineage leukemia (MLL) locus at 11q23. It remains unclear why this group has a particularly poor outcome independent from patient age. 1 Significant advances have been made in understanding the molecular consequences of 11q23 translocations using mouse models, but the need for new strategies to target this cytogenetically defined group of leukemias justifies further investigation into molecular pathways regulated by MLL. 2 The protein encoded by the MLL gene (Mll1 in mouse) is a large nuclear chromatin-modifying protein that encodes histone methyltransferase activity. 3, 4 In addition to its methyltransferase activity, MLL possesses sequence-nonspecific DNA recognition motifs [5] [6] [7] and chromatin recognition motifs. 8, 9 Much of the chromatin-targeting activity is retained in the N-terminus and is thus shared between MLL and oncogenic MLL fusion proteins. Therefore, it is not surprising that many genes identified as overexpressed in cells harboring MLL translocations are also natural MLL target genes. 10 The extent to which MLL fusion proteins simply hyperactivate a natural MLL-dependent haematopoietic program or alternatively, exhibit neomorphic activity (acquiring and deregulating new target genes), remains unclear, but this distinction is critical for the development of targeted therapeutics.
To understand the normal role of wild-type Mll gene in the haematopoietic system, our group and others have performed gene disruption experiments to generate loss-of-function alleles using a variety of strategies. [11] [12] [13] [14] [15] Owing to the large and complex nature of the Mll1 locus, none of these gene disruptions produce null alleles, and all (with the exception of the SET (Su(var)3-9, enhancer of zeste, trithorax) domain deletion 14 ) result in embryonic lethality when homozygous. The age of embryonic lethality varies amongst alleles, suggesting that residual function of the different alleles may cause the variable results reported. Furthermore, Mll expression in the embryo is dynamic and widespread and the cause of lethality has not been clearly elucidated. For these reasons, we and others, 15 have developed conditional knockout alleles to more precisely assess the role of Mll in adult haematopoietic cell types and in other tissues.
To produce a conditional loss-of-function allele, our group generated an Mll allele in which exons 3 and 4 are loxP-flanked (Mll F ). 16 We demonstrated that the excision of exons 3 and 4 (producing the Mll DN allele) results in an in-frame deletion and the resulting MLL DN protein can not be imported into the nucleus because of the loss of nuclear localization motifs. The cytoplasmic localization was demonstrated in cells expressing an epitope-tagged version of the MLL DN protein as well as in Mll-deleted primary cells. 16 In addition, the AT hooks, 5 methylation status-specific DNA recognition motifs, 6, 7 and subnuclear targeting motifs 17 are lacking in the MLL DN protein. These motifs are essential for transformation in the context of MLL-ENL (eleven;nineteen leukemia) fusion oncoproteins. 6 In an independent study, McMahon et al. 15 generated an Mll F allele, in which exons 8 and 9 are excised, also resulting in an in-frame deletion. The protein produced from this allele is likely unstable; MLL is undetectable by immunoblot in mutant fetal liver extracts. Interestingly, both gene disruption strategies result in several very similar phenotypes such as embryonic lethality of germline homozygotes beginning at BE12.5, inefficient fetal liver haematopoiesis and adult bone marrow cells that fail to engraft secondary recipients. However, one significant phenotypic difference distinguished these two conditional knockout models. In the McMahon et al. 15 study, the pan-haematopoietic, VavCre-mediated deletion resulted in efficient Mll excision in all haematopoietic cells, with no effect on steady-state haematopoietic populations. Despite normal steady-state haematopoiesis, bone marrow cells from these animals exhibited a severe defect in engrafting secondary recipients. Thus, based on this mouse model, the authors concluded that Mll is only required for the process of regenerating the haematopoietic system but not for steady-state haematopoiesis. In contrast, our studies using the inducible Mx1Cre transgene 18 demonstrated an absolute requirement for Mll in steady-state as well as regenerative haematopoiesis. We observed a significant reduction in haematopoietic stem cell function as early as 4 days after deletion of Mll followed by a rapid decline in most bone marrow cells and lethality 2-3 weeks after deletion. 16 Two major differences between these mouse models may account for the different conclusions. First, the proteins encoded by the two different alleles may retain some quantitatively or qualitatively different residual functions. Second, the method of excision (Mx1Cre versus VavCre) may impact on the effects of Mll loss. The Mx1Cre transgene is widely used to evade embryonic lethality and introduce Cre-mediated gene manipulations into the haematopoietic system. 19 The induction of Cre expression is initiated in adult animals by the injection of polyinosinic-polycytidylic acid (pI:pC), a double stranded NA analog. Toll-like receptor 3 mediated recognition of double stranded RNA initiates the expression of type I interferons (IFNs), which result in the activation of the Mx1Cre transgene. 18 Systemic IFNs affect many developing and mature haematopoietic cell types, often limiting the use of the Mx1Cre model to periods after recovery from transient pI:pC-initiated nonspecific effects. Type I IFNs are potent inhibitors of normal haematopoietic cell progenitor growth including lymphoid, 20, 21 erythroid and myeloid cell types. 22, 23 In addition, a proproliferative role of IFNa on haematopoietic stem cells has been demonstrated recently. 24, 25 Therefore, any assessment of haematopoietic phenotypes using the Mx1Cre model should take into account the potential for combined effects of the engineered mutation and IFN signaling.
As targeting MLL fusion oncoproteins may include strategies that inadvertently target endogenous MLL, it is important to determine whether the inhibition of endogenous MLL activity could be tolerated. Therefore, the objective of this study was to reassess the role of Mll in adult and fetal haematopoiesis using a method not requiring induction of IFNs. To this end, we generated and analyzed animals in which haematopoieticspecific Mll excision is achieved using a VavCre transgene. In this study, we show that the developmentally regulated excision of our Mll F allele largely phenocopies the acute excision using the Mx1Cre transgene, supporting the conclusion that Mll is required to sustain adult steady-state haematopoiesis.
Materials and methods

Animals
Mice were maintained in compliance with the Dartmouth Animal Resources Center and Institutional Animal Care and Use Committee policies. Mll F alleles and gene targeting have been described previously. 13 Mll DN animals were generated by crossing EIIa-Cre transgenics (Jackson Labs, Bar Harbor, ME, USA) to Mll F animals and selecting progeny that transmitted the deleted (Mll DN ) version of the allele. VavCre mice were obtained from Hanna Mikkola (University of California, Los Angeles, CA, USA) with permission from Thomas Graf (Center for Genomic Regulation, Barcelona, Spain). Rosa26-YFP (RosaYFP) reporter mice were obtained from Jackson Labs (stock no. 006148). Embryo age was defined as day 0.5 at 0800 hours the day of plug observation. To screen out germline and mosaic expression of the VavCre transgene, embryos harboring the RosaYFP allele were imaged after dissection or non-haematopoietic tissues were assessed for Mll excision using a quantitative genomic PCR assay 16 using tail, limb bud, somite or head genomic DNA. A similar approach was used to screen adult VavCre animals, using ear, tail or liver genomic DNA.
Flow cytometry and differential blood counts
Bone marrow cells were prepared and lineage staining was performed as previously described 16, except that the F 0 ab 2 antirat conjugate was a PE-Cy5.5 reagent (Invitrogen, Carlsbad, CA, USA). Splenocytes and thymocytes were prepared by trituration through a 40-micron nylon filter. For splenocytes and bone marrow, RBC lysis buffer (eBioscience, San Diego, CA, USA) was used to remove red blood cells. For adult bone marrow, lineage cocktail consisted of unlabeled rat anti-Gr-1, Mac-1, interleukin-7Ra, Ter119, CD3, CD4, CD8, B220 and CD19, all from Invitrogen except that interleukin-7Ra antibody was obtained from eBioscience. For the fetal liver analyses, lineage cocktail lacked the Mac-1 antibody. In some experiments, goat anti-rat APC (BD Biosciences, San Jose, CA, USA) was used in conjunction with Sca-1 biotin, c-Kit PE, CD48 FITC and streptavidin-PECy5.5 all from BD Biosciences. T cell analyses utilized anti-CD3, CD4, CD8, CD25, CD44, CD45.1 and CD45.2 from BD Biosciences or eBioscience. Flow cytometry was performed with a FACSCalibur or FACSAria (BD Biosciences) and data was analyzed using FlowJo Software (TreeStar Inc., Ashland, OR, USA). Peripheral blood collected from the periorbital sinus was analyzed using a Hemavet 950 blood analyzer (Drew Scientific, Inc, Dallas, TX, USA).
In vitro colony assays and transplantation experiments
Colony assays to enumerate myeloerythroid colony-forming units were performed by plating unfractionated fetal liver or bone marrow cells in 1 ml M3434 (Stemcell Technologies, Vancouver, BC, Canada) in duplicate. Total colonies were enumerated 6-7 days after plating. Competitive transplantation assays were performed using C57Bl/6 female mice irradiated with a split dose of 950 Rads. Each recipient received 2 Â 10 5 protective C57Bl/6 bone marrow cells and either 5 Â 10 4 or 5 Â 10 5 fetal liver cells. Engraftment was assessed by the presence of Ly5.1 þ (fetal donor) cells in the peripheral blood of recipients by flow cytometry.
Statistical analysis and software
Unless otherwise indicated, unpaired Student's t-tests were used to calculate P-values. All error bars represent 95% confidence intervals unless otherwise indicated in the figure legend. Graphs and statistical tests were performed using Prism (Graphpad, La Jolla, CA, USA) or Excel (Microsoft Corporation, Redmond, WA, USA).
Histology and imaging
For bone marrow sections, the sternum was removed, cleaned and transferred to Bouin's fixative overnight at 4 1C. Fixed samples were processed by the Dana-Farber/Harvard Cancer Center Rodent Histopathology Core Facility. Samples were imaged on a Nikon Optiphot-2 microscope using Â 10 and Â 40 objectives for a total magnification of Â 100 and Â 400.
Images were manipulated using Adobe Photoshop and Illustrator software (Adobe Systems, Inc., San Jose, CA, USA). Embryo images were acquired on a Leica MZFIII stereomicroscope using a GFP-470 filter (Chroma Technology, Bellows Falls, VT, USA), Color Mosaic 11.2 camera and Spot Insight 4.0 software (Diagnostic Instruments, Sterling Heights, MI, USA). Total magnification was 6.3X-8X.
Results
VavCre-mediated gene deletion becomes fully penetrant by embryonic day (E) 13.5
Several groups have generated Cre recombinase-expressing transgenic animals using regulatory elements of the vav1 gene. [26] [27] [28] [29] To determine the first point at which VavCremediated excision becomes fully penetrant in an haematopoietic stem cell-enriched population, we analyzed fetal livers from wild-type VavCre embryos harboring the RosaYFP reporter gene. Excision of RosaYFP increased rapidly from E12.5 in lineage-negative, Sca-1 þ c-Kit þ (LSK) cells, approaching 100% at E13.5 (Figure 1a ). Depending on the regulatory elements used, vav transgenes have been observed to exhibit variegated or ectopic expression. 26, 28, 29 We observed that up to 20% of the progeny of VavCre;Mll F/ þ X Mll F/F crosses had undergone either germline excision (most tissues had undergone Mll excision) or mosaic excision (patchy excision outside the haematopoietic system). The remaining animals exhibited faithful expression of the VavCre transgene exclusively in the fetal liver at E13.5. The aberrant excision was most apparent when embryos harbored the RosaYFP allele to visualize all tissues in which Cre expression had occurred (Figures 1b-e ). To reduce the mosaic and germline expression of the VavCre transgene, an alternative breeding strategy was also used (VavCre;Mll DN/ þ X Mll F/F ). In this strategy, the animal that harbored the Vav transgene also had one 'pre-deleted' Mll allele (Mll DN ), thus avoiding Mll excision through ectopic VavCre activity in germ cells, as had been previously reported. 26, 28 This strategy increased the number of animals exhibiting haematopoietic-specific Mll excision and also increased the penetrance of the phenotypes observed.
Normal fetal haematopoietic expansion in VavCre;Mll mutant embryos
Using germline Mll alleles, several groups have reported inefficient fetal liver haematopoiesis. 15, 30 To determine whether the loss of Mll exclusively in developing haematopoietic cells results in a similar effect on fetal liver cellularity, we analyzed fetal haematopoiesis in VavCre;Mll F/F embryos from E13.5 to E17.5, with and without the RosaYFP allele. Although full penetrance of Cre excision in the fetal liver is achieved by E13.5, no reduction in cellularity was observed, even by E15.5 in either VavCre;Mll F/F or VavCre;Mll DN/F embryos (Figures 2a, d and g). Furthermore, the haematopoietic stem cell-enriched LSK/CD48-negative population 31 was also not reduced (Figures 2b, c, e and f). In contrast to the significant decrease in B cells in adult mutant mice (see , a comparable number of B220 þ CD19 þ cells were observed in VavCre;Mll mutant relative to wild-type fetal livers (Figure 2h ). This was also true within the YFP-gated population, further demonstrating that cells that had expressed Cre recombinase were equally able to generate B-lineage cells in vivo (Figure 2i ). Thus, haematopoietic-specific loss of Mll during development does not hinder haematopoietic expansion or the generation of B-lineage cells in the fetal liver.
Function of Mll-deficient fetal haematopoietic cells
The surprisingly normal fetal haematopoietic development in VavCre;Mll mutants prompted us to test these cells in several quantitative functional assays, including myeloerythroid colony assays and competitive transplantation assays. Similar to our observations using adult bone marrow, 16 we found that Mll-deficient fetal liver cells yielded 2.6-fold reduced (Figure 3a) . We also performed competitive engraftment assays using VavCre;Mll F/F fetal liver cells. In these experiments, we could not detect VavCre;Mll F/F embryo-derived cells in the peripheral blood of recipients, even as early as 4 weeks after transplant (Figures 3b-c) . These data illustrate that despite the normal phenotype and developmental expansion of fetal haematopoietic cells, Mll-deficient stem and progenitor cells are functionally impaired, particularly in their ability to engraft into an adult environment.
Postnatal multilineage haematopoietic defects in VavCre;Mll mutants
In contrast to the embryonic lethality observed in germline Mll mutants 11, 13, 15 VavCre;Mll mutants were born (Table 1) , but postnatal differences between these mutants and their littermates became immediately apparent. Our first attempts to produce adult mutant animals used the VavCre;Mll F/ þ X Mll F/F breeding strategy. The genotypes of 3-week old animals revealed less than half the expected Mendelian ratio of VavCre;Mll F/F animals ( Table 1 ). The surviving mutant animals were smaller than their littermates (Supplementary Figure S1 ) and exhibited incomplete gene excision in bone marrow and thymocyte populations (Supplementary Figure S2-S3 ), suggesting that cells escaping Mll deletion contributed to animal survival. Close observation of pups born from this breeding strategy demonstrated that most mutants were moribund or died between 2-3 weeks of age (unpublished data). Histological analysis of bone marrow sections illustrated the overall reduced cellularity and also the paucity of megakaryocytes in VavCre;Mll F/F animals (Figures 4a-d, arrows) , similar to what we had observed after inducing Mll deletion in adult bone marrow. 16 Enumerating LSK cells in the bone marrow revealed a sixfold reduction in VavCre;Mll F/F animals (Figure 4e ). Examination of the more penetrant VavCre;Mll DN/F animals revealed a 4100-fold reduction in all lin À /c-Kit þ cells ( Supplementary Figure 4) . As a result, all stem and progenitor populations defined by c-Kit expression were severely reduced, and these animals did not survive beyond 3 weeks of age. In contrast, some VavCre;Mll F/F animals survived beyond this age. Despite the incomplete excision of Mll in these surviving VavCre;Mll F/F animals, they afforded an opportunity to assess the effects of Mll loss on multiple lineages in the haematopoietic system without the potentially confounding effects of pI:pC, as had limited our previous studies using Mx1Cre;Mll inducible mutants.
Analysis of the peripheral blood of surviving 3-to 5-week old VavCre;Mll F/F mice showed significant deficiencies in white blood cells, red blood cells and platelets, as well as an increased mean red blood cell corpuscular volume ( Figure 5 ). These defects were also observed in pI:pC-induced Mx1Cre;Mll F/F To determine the consequences of VavCre-mediated Mll deletion on developing lymphocytes and lymphocyte progenitors, populations in the bone marrow and thymus were analyzed in the same surviving animals as described above. Total B220 þ in the bone marrow were reduced ninefold (Figure 6a ). Common lymphoid progenitors (lin À /interleukin-7Ra þ /c-Kit þ / Sca-1 þ ) were also reduced over fivefold in VavCre;Mll F/F animals (Figure 6b ). More detailed analysis of developing B cells revealed consistent reductions throughout B cell development (Figures 6c-e, Supplementary Figure 5 ). However, these data likely underestimate the severity of haematopoietic phenotypes because of the poor and variable penetrance of the VavCre transgene particularly in the B cell lineage of VavCre;Mll mutants ( Supplementary Figure 2) .
Within the thymus, the reduction in thymocyte number (4.6-fold) was largely attributable to the CD4 þ /CD8 þ doublepositive population (Figure 7a) . In contrast to B-lineage cells, thymocytes consistently demonstrated high levels of Mll excision (unpublished data) and RosaYFP excision (Supplementary Figure 3 ). Within the double-negative (DN) population, a specific reduction in CD25 þ cells was observed ( Figure 7b ). As thymus-seeding cells are within the bone marrow LSK population 32 and this population is significantly reduced in VavCre;Mll F/F animals, (Figure 4e ) it is likely that input of progenitors from the bone marrow limits T cell development. In support of this hypothesis, excision of Mll at the DN3-DN4 transition with an LckCre transgene 16 or with a Rag1Cre knock-in (Gan et al. in preparation) had no effect on thymocyte numbers. In the first row, the progeny of crosses consisting of VavCre;Mll F/+ animals mated to Mll F/F animals (with or without the RosaYFP allele) were genotyped at 21 days of age (observed) and compared with the number based on Mendelian inheritance (expected). The second line represents the same analyses for the breeding strategy using one germline excised Mll allele (Mll DN ) in the female, VavCre;Mll DN/+ , crossed to Mll F/F males. The percentage of homozygous mutant animals genotyped at 21 days is indicated.
Mll1 is essential for postnatal haematopoiesis T Gan et al In summary, the developmental excision of Mll in haematopoietic cells results in substantial multi-lineage haematopoietic defects that only become apparent after birth, or by transplanting cells into an adult animal. Using a breeding strategy that results in the more penetrant phenotypes (VavCre;Mll D/F ), most animals succumb to bone marrow failure between birth and 3 weeks of age. However, examination of adult animals harboring a less penetrant allele combination (VavCre;Mll F/F ) revealed additional defects in B cell development. Collectively, these data support the conclusion that Mll1 is essential for the establishment and maintenance of adult haematopoiesis.
Discussion
The primary goal of this study was to reassess the severity of Mll deficiency in the absence of the potential confounding effects of systemic IFNs. Using the developmentally regulated VavCre transgene, we demonstrate that animals lacking Mll specifically in haematopoietic cells exhibit a range of haematopoietic phenotypes very similar to those we observed upon acute excision of Mll using the Mx1Cre transgene. These include hypocellular bone marrow, a dramatic reduction in the number of primitive (c-Kit þ , lineage negative) haematopoietic cells, anemia, thrombocytopenia and reduced numbers of developing lymphocytes. The consistency between these two conditional knockout approaches indicates that the haematopoietic failure observed in Mx1Cre;Mll F/F mutants was likely because of Mll loss and not the combined effect of Mll loss and IFN signaling. Therefore, we conclude that Mll has an essential, non-redundant role during the establishment of adult steadystate haematopoiesis.
In this study, we found that the in vivo expansion of VavCre;Mll F/F fetal haematopoietic cells proceeds normally. However, Mll-deficient fetal liver haematopoietic cells exhibit reduced colony-forming potential and competitive engraftment capability, revealing an inherent functional deficit in these cells. The fact that we find no haematopoietic-intrinsic defect in fetal liver cellularity or phenotype is consistent with the results of McMahon et al. 15 , who also reported defects in fetal haematopoiesis only in the context of their germline knockout of Mll and not their VavCre conditional knockout. Therefore, the reduction in fetal liver cellularity observed using traditional germline knockouts may be because of the cell-extrinsic contributions of Mll loss in non-haematopoietic tissues such as endothelial or other stromal support cells. Alternatively, the Mll1 is essential for postnatal haematopoiesis T Gan et al severity of germline mutants may be due to an early developmental role for Mll such as in the hemangioblast, which would be affected in germline but not VavCre Mll mutants. This VavCre transgene is not expressed in endothelial cells or hemangioblasts, making it a valuable tool to exclude contributions from these tissues. 29, 33 More detailed analyses using endothelialspecific and temporally regulated transgenes will be necessary to account for the differences between germline and VavCre mutants. The differences between our results and those of McMahon et al. with respect to the role of Mll in steady-state adult haematopoiesis are most easily explained by differences in the severity of the knockout allele, not the method of deletion. Both mutant alleles are associated with loss-of-function Mll phenotypes, yet the Mll DN allele exhibits more severe defects in haematopoiesis. The molecular mechanism behind the severity of the Mll DN allele likely lies in the fact that it is not only retained outside of the nucleus but also lacks important functional motifs for targeting chromatin. Although the allele used in the McMahon et al. study is thought to produce no protein, given the technical challenges of detecting MLL by immunoblot in primary cell types, it is possible that this approach produces a low level of partially active protein that can access the nucleus.
An important observation from our VavCre;Mll F/F animals that was obscured using the Mx1Cre inducible transgenic model is the selective reduction in developing and peripheral B cells. A nonspecific reduction in B cells persists up to 15 days after pI:pC injection using our experimental conditions (unpublished data), thus it is likely that the effect of Mll loss was obscured by the global B cell reduction in pI:pC injected animals. The selective reduction in B-lymphopoiesis observed in VavCre mutants recalls the clinical observation that MLL-rearranged acute lymphocytic leukemia (ALL) is predominantly precursor-B cell ALL and is rarely T cell ALL. 34, 35 In fact, among patients with MLL translocations, the T-ALL group has a much more favorable outcome than the B-ALL group. 36 Therefore, the selective and persistent reduction in B lymphocytes observed in VavCre;Mll F/F mutants suggests that MLL controls unique and important pathways in developing B cells that may be deregulated by MLL fusion oncoproteins. Future studies in which Cre recombinase is expressed specifically in early lymphocyte populations, thus sparing all other Mll-dependent cell types in the bone marrow, will be essential for dissecting a potential B-lymphocyte specific function of MLL. CD4-or CD8-expressing thymocytes were excluded from the analysis, and CD44 versus CD25 expression is shown on the remaining DN cells. Data from four representative animals is shown for the genotypes indicated at the right of each row.
Our data have important implications for the development of strategies to target MLL associated leukemia. First, the results presented here further support our conclusion 16 that targeting oncogenic MLL fusion proteins through direct inhibition of the N-terminus, which is shared with endogenous wild-type MLL may have the undesirable effect of suppressing ongoing normal haematopoiesis. This is particularly problematic, because structure-function relationships in the N-terminus have been extensively interrogated, and molecules that directly target the N-terminus of MLL could be used against a wide variety of MLL fusions differing in C-terminal fusion partner. An ideal targeted therapeutic would act exclusively on the aberrant activity of the oncogenic fusion protein, yet this degree of selectivity is difficult to achieve. Thus the viability of an MLL N-terminal targeting molecule may depend on identifying a therapeutic index distinguishing the activities of MLL fusion proteins from those of endogenous MLL. Mll loss-of-function models will help define the pathways required for normal haematopoiesis relative to those deregulated by MLL fusion proteins, perhaps guiding alternative strategies for selectively targeting the actions of leukemogenic MLL fusion proteins.
